Vaginal trichomoniasis: Clinical sciences

test

00:00 / 00:00

Vaginal trichomoniasis: Clinical sciences

Focused chief complaint

Abdominal pain

Approach to biliary colic: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Acute coronary syndrome: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Adnexal torsion: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Aortic dissection: Clinical sciences
Appendicitis: Clinical sciences
Approach to ascites: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Chronic pancreatitis: Clinical sciences
Colonic volvulus: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Diverticulitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Endometriosis: Clinical sciences
Gastritis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Ileus: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inguinal hernias: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Lower urinary tract infection: Clinical sciences
Malaria: Clinical sciences
Nephrolithiasis: Clinical sciences
Paraesophageal and hiatal hernia: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pulmonary embolism: Clinical sciences
Pyelonephritis: Clinical sciences
Rectus sheath hematoma: Clinical sciences
Retroperitoneal hematoma: Clinical sciences
Sickle cell disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences

Altered mental status

Approach to altered mental status: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Alcohol withdrawal: Clinical sciences
Approach to encephalitis: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to hypocalcemia: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to schizophrenia spectrum and other psychotic disorders: Clinical sciences
Approach to shock: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Delirium: Clinical sciences
Diabetic ketoacidosis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Hypothermia: Clinical sciences
Hypovolemic shock: Clinical sciences
Lower urinary tract infection: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Pyelonephritis: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Substance use disorder: Clinical sciences
Uremic encephalopathy: Clinical sciences

Assessments

USMLE® Step 2 questions

0 / 3 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

A 24-year-old G1P0 woman at 29 weeks gestation presents to the primary care office for evaluation of three days of malodorous vaginal discharge and vaginal itching. She reports an episode of unprotected intercourse with a new biologically male partner two weeks prior. Temperature is 37.0°C (98.6°F), pulse is 92/min, respiratory rate is 18/min, and blood pressure is 118/78 mmHg. Chaperoned vaginal examination reveals a green, frothy vaginal discharge. There is no cervical motion tenderness or suprapubic pain. The vaginal pH is 4.8.  Saline microscopy of the vaginal fluid reveals motile, pear-shaped microorganisms and many polymorphonuclear white blood cells.  Which of the following is the best next step in management?

Transcript

Watch video only

Vaginal trichomoniasis is among the most prevalent sexually transmitted infections, or STIs, worldwide. It is caused by the protozoan parasite, Trichomonas vaginalis. Most patients infected with trichomonas have minimal or no symptoms, and untreated infections can last for months to years. Trichomonas infection is associated with an increased risk of both HIV acquisition and HIV shedding, and it increases the risk of pelvic inflammatory disease among HIV-positive patients. Additionally, it has been associated with an increased risk of cervical cancer. In pregnancy, trichomonas infection increases the risk of preterm birth, prelabor rupture of membranes and small for gestational age infants.

Your first step in evaluating a patient who presents with a chief concern suggesting vaginal trichomoniasis is obtaining a focused history and physical exam. This should include a sexual history, such as recent sexual activity or new partners, so be sure to have a private and confidential discussion. Although it might be difficult, you should ask caregivers of young patients to step out of the room for this discussion. Additionally, always consider sexual assault or abuse whenever a young patient has a positive sexual activity history, especially if the patient is a child. If there is abuse going on, you will need to follow up with allegations of abuse in accordance with your State’s law.

Now, keep in mind that trichomoniasis can be spread through vaginal fluids So some practices like sharing of sex toys can cause infection. In addition to sexual history, ask about hygiene practices, such as douching, which can remove some of the bacteria that make up the normal vaginal flora, increasing the risk of overgrowth of infectious pathogens. Although most patients are usually asymptomatic, some may report a malodorous vaginal discharge, vulvar pruritus or irritation, and dysuria.

Physical exam findings include a yellow frothy vaginal discharge; as well as vaginal or cervical erythema with petechiae, which is often referred to as a “strawberry cervix.” Based on these findings, you should suspect vaginal trichomoniasis.

Here is a high-yield fact! In the United States, the prevalence of vaginal trichomoniasis is almost 10 times higher among black patients than non-Hispanic white patients. Some additional risk factors for trichomonas infection include socioeconomic factors like incarceration, having less than a high school education, and poverty.

So, if you suspect vaginal trichomoniasis, let’s take a look at your next step to confirm the diagnosis. To do this, obtain samples of the vaginal discharge from the vaginal walls and fornices. Evaluate the discharge with saline microscopy, particularly looking for motile trichomonads, and assess the vaginal pH. In addition, you may perform nucleic acid amplification testing, or NAAT, for Trichomonas vaginalis. While NAAT testing is highly sensitive and detects more trichomonas infections, keep in mind that it’s more expensive and less timely than microscopy.

Okay, time for a couple of clinical pearls! First, vaginal cultures can be used to detect Trichomonas vaginalis, but these are rarely used, as NAAT testing has higher sensitivity and better detection rates. Additionally, there are also some FDA-approved rapid tests available for detecting Trichomonas vaginalis. Second, vaginal trichomoniasis has a high prevalence in patients with HIV infection, can increase viral shedding, and is strongly associated with pelvic inflammatory disease among these patients. For these reasons, yearly screening for trichomonas is recommended for patients with HIV infection.

Now let’s review our results. If there is an absence of trichomonads on saline microscopy, the vaginal pH is lower than or equal to 4.5, or a NAAT is negative for Trichomonas, consider an alternative diagnosis. However, keep in mind that time matters here, and sensitivity decreases quickly within 1 hour after specimen collection, so you should attempt to evaluate it immediately!

Sources

  1. "Sexually transmitted infections treatment guidelines, 2021. 70(No. RR-4):1–187" MMWR Recomm Rep (2021)
  2. "ACOG practice bulletin no. 215: Vaginitis in nonpregnant patients. 135 (1):e 1-17." Obstet Gynecol (2020)